Eisai Co., Ltd.

6.61

+0.05000.76%

Volume:178.48K

Turnover:1.17M

Market Cap:7.52B

PE:37.35

High:6.61

Open:6.56

Low:6.50

Close:6.56

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

As baby boomers turn 80, there aren't enough doctors to treat 'emergency levels' of dementia patients

Dow Jones

·

01 Mar

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ESAIY"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ESAIY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESAIY\",,,,,undefined,":{"symbol":"ESAIY","market":"US","secType":"STK","nameCN":"Eisai Co., Ltd.","latestPrice":6.61,"timestamp":1752696000000,"preClose":6.56,"halted":0,"volume":178483,"delay":15,"floatShares":1076747898,"shares":1137465824,"eps":0.176978,"marketStatus":"Closed","change":0.05,"latestTime":"07-16 16:00:00 EDT Delay","open":6.56,"high":6.613,"low":6.5,"amount":1174380.8852000001,"amplitude":0.017226,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.176978,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1752739200000},"marketStatusCode":5,"adr":0,"adrRate":0.25,"exchange":"PINK LIMITED","adjPreClose":6.56,"volumeRatio":0.961956},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ESAIY\",,,,,undefined,":{"symbol":"ESAIY","floatShares":1076747898,"roa":"2.12%","roe":"5.45%","lyrEps":0.244385,"volumeRatio":0.961956,"shares":1137465824,"dividePrice":0.2696,"high":6.613,"amplitude":0.017226,"preClose":6.56,"low":6.5,"week52Low":5.94,"pbRate":"1.33","psRate":"1.41","week52High":10.75,"institutionHeld":0,"latestPrice":6.61,"eps":0.176978,"divideRate":0.040787,"volume":178483,"delay":15,"ttmEps":0.176978,"open":6.56,"prevYearClose":6.74,"prevWeekClose":6.73,"prevMonthClose":7.15,"prevQuarterClose":7.15,"fiveDayClose":6.89,"twentyDayClose":6.92,"sixtyDayClose":6.79},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ESAIY\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ESAIY\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516598405","title":"As baby boomers turn 80, there aren't enough doctors to treat 'emergency levels' of dementia patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2516598405","media":"Dow Jones","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516598405?lang=en_us&edition=fundamental","pubTime":"2025-03-01 21:25","pubTimestamp":1740835500,"startTime":"0","endTime":"0","summary":"'Dementia neurology deserts' already exist in 20 states. The future looks even more bleak.As the oldest baby boomers turn 80 this year, the medical industry is already overtaxed in its ability to provide dementia care - let alone handle the expected barrage of cases in the future.\"It's a dire situation. It's already at emergency levels - to get a diagnosis, to get care, and all the points along the way,\" said Elizabeth Edgerly, senior director of community programs and services with the Alzheimer's Association. \"As the baby boomers age, the disconnect between supply and demand is growing larger.\". The lifetime risk of dementia after age 55 is about 42%, according to a recent study published in the journal Nature Medicine. Around 1 million adults in the U.S. are projected to develop dementia each year by 2060, compared with around 514,000 in 2020, the study found. More than 6 million Americans currently have Alzheimer's disease.The average wait time to see a neurologist is 34 days natio","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0238689110.USD","LU0354030438.USD","LU1989771016.USD","LU1983299246.USD","LU0203202063.USD","LU0882574055.USD","BIIB","ESAIY","BK4007","LU0097036916.USD","LU0385154629.USD","LU0114720955.EUR","SG9999014914.USD","LU0079474960.USD","LU1057294990.SGD","LU1127390331.HKD","BK4516","LU0320765059.SGD","LU0354030511.USD","LU2468319806.SGD","LU0708995401.HKD","SGXZ99366536.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0094547139.USD","IE00BK4W5L77.USD","LU0943347566.SGD","LU1280957306.USD","LU0256863811.USD","LU2237443549.SGD","LU0823416689.USD","IE00BJT1NW94.SGD","LU2237443465.HKD","LU0096364046.USD","LU1366192091.USD","SG9999014898.SGD","LU0672654240.SGD","SG9999015986.USD","SGXZ51526630.SGD","LU0820561818.USD","LU2491050154.USD","LU1035775433.USD","LU0061475181.USD","LU0234570918.USD","IE00B19Z9P08.USD","BK4588","SG9999015945.SGD","LU0106261372.USD","IE0009355771.USD"],"gpt_icon":1},{"id":"2514321173","title":"Biogen, Eisai announces CHMP of EMA reaffirmed positive opinion of lecanemab","url":"https://stock-news.laohu8.com/highlight/detail?id=2514321173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514321173?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:17","pubTimestamp":1740748632,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biogen-eisai-announces-chmp-of-ema-reaffirmed-positive-opinion-of-lecanemab?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biogen-eisai-announces-chmp-of-ema-reaffirmed-positive-opinion-of-lecanemab?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0320765992.SGD","LU0889565916.HKD","IE00B19Z9Z06.USD","CHMP","LU0234570918.USD","BK4533","IE00B19Z9P08.USD","BK4007","BIIB","ESAIY","BK4588","BK4532","IE00B894F039.SGD","BK4087","LU0109394709.USD","BK4139"],"gpt_icon":0},{"id":"2506397886","title":"FDA approves Eisai, Biogen’s sBLA for lecanemab-irmb IV dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2506397886","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506397886?lang=en_us&edition=fundamental","pubTime":"2025-01-27 08:20","pubTimestamp":1737937204,"startTime":"0","endTime":"0","summary":"Eisai (ESAIY) and Biogen (BIIB) announced that the U.S. Food and Drug Administration, FDA, has approved the Supplemental Biologics License Applicat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-eisai-biogens-sbla-for-lecanemab-irmb-iv-dosing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-eisai-biogens-sbla-for-lecanemab-irmb-iv-dosing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIIB","BK4588","IE00B19Z9Z06.USD","BK4532","LU0889565916.HKD","BK4585","IE00B894F039.SGD","BK4139","IE00B19Z9P08.USD","ESAIY","LU0109394709.USD","BK4007","BK4533","LU0234570918.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2503653805","title":"FDA accepts Eisai/Biogen’s BLA for LEQEMBI in early AD treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2503653805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503653805?lang=en_us&edition=fundamental","pubTime":"2025-01-14 08:22","pubTimestamp":1736814145,"startTime":"0","endTime":"0","summary":"The company states: “Eisai (ESAIY) and Biogen (BIIB) announced that the FDA has accepted Eisai’s Biologics License Application, BLA, for lecanemab-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-accepts-eisai-biogens-bla-for-leqembi-in-early-ad-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-accepts-eisai-biogens-bla-for-leqembi-in-early-ad-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ESAIY","LU0109394709.USD","BK4588","IE00B19Z9P08.USD","LU0320765992.SGD","BK4139","IE00B894F039.SGD","BK4007","BIIB","BK4532","IE00B19Z9Z06.USD","LU0234570918.USD","BK4533","LU0889565916.HKD"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ESAIY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-06","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"post","actualEps":null},{"date":"2024-08-01","symbol":"ESAIY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722542400000,"name":null,"time":"Post Market","dateTimestamp":1722484800000,"actualEps":null},{"date":"2024-05-14","symbol":"ESAIY","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715716800000,"name":null,"time":"Post Market","dateTimestamp":1715659200000,"actualEps":null},{"market":"US","date":"2024-02-05","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707109200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-11-07","symbol":"ESAIY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1699333200000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ESAIY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ESAIY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1333,"buy":0.2,"hold":0.6,"sell":0.0667,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6,"analysts":15,"updateTime":1749528000000}}}